1-fluoro-7-chloroheptane | CAS:334-43-0

We serve 1-fluoro-7-chloroheptane CAS:334-43-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-fluoro-7-chloroheptane

Chemical Name:1-fluoro-7-chloroheptane
CAS.NO:334-43-0
Synonyms:1-Fluoro-7-chloroheptane
1-chloro-7-fluoroheptane
7-Fluoroheptyl chloride
Heptane,1-chloro-7-fluoro
Heptane, 1-chloro-7-fluoro-
Molecular Formula:C7H14ClF
Molecular Weight:152.6374632
 
Physical and Chemical Properties:
Density:0.9930
Boiling point:185.77ºC
Index of Refraction:1.4222
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
Moisture:≤0.05%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 1-fluoro-7-chloroheptane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Heptane, 1-chloro-7-fluoro- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-fluoro-7-chloroheptane Use and application,Heptane, 1-chloro-7-fluoro- technical grade,usp/ep/jp grade.


Related News: “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.2-Cyano-3-Nitropyridine manufacturer Vietnam backtracked on Saturday and narrowed its restrictions to most flights from mainland China.(2E)-2-(1,2,6,7-tetrahydrocyclopenta[e][1]benzofuran-8-ylidene)acetonitrile supplier Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients.N-(2,6-Dimethylphenyl)chloroacetamide vendor The Philippines reported its first Wuhan coronavirus fatality on Sunday.GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.”